AGP Executive Report

Neurological Health: Céline Dion fell during her Paris residency but quickly got back up and continued performing. The singer has stiff-person syndrome, a rare disorder that causes muscle stiffness and spasms. Fitness and Wellness: Basic-Fit has joined Wellhub’s French employee-wellness network, giving staff at participating companies access to more than 900 of the gym chain’s clubs. Living with Coeliac Disease: A traveller’s experience in France highlights the challenge of finding safe gluten-free food, especially outside major cities, and the need to guard against even tiny amounts of gluten. Mosquito-borne Illness: West Nile virus cases have increased in southeastern France, as warmer autumn weather keeps mosquitoes active.

Space Medicine: French astronaut Sophie Adenot returned from the ISS after a record 237 days in orbit. Her crew had been sent up after an earlier team member fell ill, prompting NASA’s first medical evacuation in 65 years of human spaceflight. Food and Farming: Farmers protested in Paris over the EU-Mercosur trade deal and the cattle disease lumpy skin disease, demanding protection for French producers and livestock. Cancer Drug Access: A Dutch court’s patent ruling blocks Merck from making or selling its under-the-skin Keytruda formulation in France and seven other European markets; the dispute does not affect standard Keytruda. Epidemic Response: France pledged more support for the Ebola response in the Democratic Republic of Congo amid fears of a resurgence. Drug Research: French chemist Henri Kagan and Japan’s Kenso Soai won the Chemistry Nobel for work on molecular asymmetry, research with potential applications in developing safer medicines.

COVID Vaccination: French authorities are weighing an earlier start to the jab campaign as cases rise, with doctors’ groups urging action. Animal Health: Shamonda virus has been found in Irish cattle after first appearing in France and other European countries in July; officials say there is no evidence it causes illness in people. Research: French chemist Henri Kagan shared the Nobel Prize for work on molecular asymmetry, a discovery that could help improve how medicines are made. Student Wellbeing: France’s student protests spotlight strained schools and support services. Free psychotherapy sessions are reportedly working well, while demand for €1 meals has far outstripped capacity. Public Health: France has adopted restrictions on PFAS, or “forever chemicals,” in some everyday products.**

Medical Research: French chemist Henri Kagan shared the Nobel Prize in Chemistry for work on molecular “handedness” that helps researchers make medicines more precisely. COVID-19: Cases are rising in France, prompting doctors’ representatives to call for early vaccination. Food Safety: A warning over possible E. coli contamination in French cheese puts food safety back in focus. Women’s Health: A report warns that staffing shortages are weakening France’s maternity wards. Prevention: France is considering extending its sugar tax to high-sugar processed foods.

Food Safety: Hong Kong authorities warned against eating a recalled batch of French Camembert after a possible E. coli contamination; the affected 250g packs have a use-by date of October 17, 2026. Covid-19: Cases are rising in France, prompting a doctors’ union to call for vaccination to begin early. Medical Research: French chemist Henri Kagan shared the 2026 Nobel Prize in Chemistry for work that helps researchers control molecule formation—an advance with important applications in drug development. Prevention: France is considering extending its sugar tax to high-sugar processed foods. Ebola Response: France has pledged further support for efforts to fight the deadly outbreak in the Democratic Republic of Congo.

Student Health & Safety: France’s nationwide lycée protests over teacher shortages, overcrowding and rundown buildings escalated into violence, with tear gas and injuries reported across multiple cities; organisers say hundreds of schools were blockaded or closed and thousands were detained, including minors, while a one-year-old was hurt by a firework during clashes near a Paris-area school. Public Health Alert: Kenya confirmed its first imported Ebola case (from the DRC via Uganda), isolating the patient in Nairobi, tracing 28 contacts and monitoring others from the same flight as authorities activate surveillance and risk communication. Clinical Research: A nationwide Serbian registry study on myotonic dystrophy reports sex differences across multiple organ systems, suggesting clinicians should treat sex as a real disease modifier for monitoring and risk planning. Healthcare Policy & Access: A France-wide campaign by the Kurdish Democratic Council in France targets youth recruitment into drug and criminal networks, pairing prevention and family support with addiction specialist sessions and community alternatives. Global Health Security: WHO and partners are responding to imported Bundibugyo virus (Kenya) with contact tracing and enhanced entry screening as the outbreak spreads beyond the DRC. Injury & Emergency Care: A 15-year-old attacker in Istanbul injured eight schoolchildren, with one in critical condition and others undergoing treatment.

Student Protests & Safety: France is bracing for another nationwide day of action as high-school pupils keep blockading schools over funding and conditions, with authorities reporting hundreds injured and police launching internal probes after allegations of disproportionate force, including cases of severe eye and hand injuries. Ebola Response: France pledged an additional €7m to support the DRC’s worst-ever Ebola crisis as Kenya confirmed its first imported Ebola death, triggering contact tracing and high-alert measures. Public Health & Innovation: OKYO Pharma says first patients are enrolled in a Phase 3 trial of urcosimod for neuropathic corneal pain, targeting a major unmet need in eye pain care. Local Ecology: A Paris suburb (Suresnes) is installing bat boxes and bird nesting sites to cut tiger mosquito numbers, betting on natural predators for a greener public-health approach. Food Safety: Taiwan intercepted US potato shipments over excessive glycoalkaloids, tightening sampling and inspections—another reminder of cross-border health risks.

Nobel Medicine: The 2026 Nobel Prize in Physiology or Medicine goes to Karl Deisseroth and German researchers Peter Hegemann and Georg Nagel for optogenetics, a technique that uses light to control cells—opening paths to better treatments for neurological and sensory disorders. Public Health & Climate: The UN warns that extreme heat is increasingly tied to pregnancy complications, including premature births and low birth weight, citing a survey showing most health professionals have seen heat-related problems. Infectious Disease Alert: Russia reports a suspected plague case after a lab worker in Siberia died of severe pneumonia; around 200 contacts were placed under observation, prompting close monitoring by European public health authorities. France Education Crisis: France braces for a nationwide day of student protests after weeks of unrest over school conditions; clashes have led to hundreds of injuries, mass arrests, and the loss of a teen’s hand. Cancer & Prevention: A new IARC analysis estimates about 12% of new cancer cases worldwide in 2024 are linked to infections, highlighting preventable drivers like HPV and H. pylori. Privacy in Care Settings: Norway is considering a temporary ban on smart glasses in public places, with concerns about filming people without consent, including in health institutions.

Public Health Alert: A 28-year-old lab technician in Russia’s Irkutsk region reportedly died of plague, with dozens placed under quarantine after possible pneumonic exposure, though officials have not yet confirmed details. Healthcare Innovation: Coave Therapeutics presented new non-human primate data in Vienna supporting its lead wet AMD gene therapy (coAAV-SCS), reporting much higher retinal/RPE-choroid expression and limited anterior exposure. Clinical Care: A study suggests a spleen stiffness cutoff could help non-cirrhotic chronic portal vein thrombosis patients safely skip some endoscopies, potentially reducing procedures while keeping high-risk varices detection low. Medication Safety: New research links GLP-1 weight-loss drugs to higher rates of hair loss and nail problems, including nail detachment and discoloration. France Water Crisis: Drought is worsening, with 83,000 people without tap water and many departments under strict restrictions. Emergency Medicine: Two men died in a Channel crossing attempt off Berck; two women were hospitalized with burns, and prosecutors opened an investigation.

Maternity Care Under Strain: A September report warns France’s maternity wards are being weakened by staffing shortages and falling activity, with fewer facilities (445 in 2024, down 16.5% since 2014) raising risks for women and newborns; the authors call for rethinking care organization, including local perinatal centers, to keep emergency coverage safe. GLP-1 Side Effects: New international dermatology data presented in Vienna links GLP-1 use to nail problems, with nail detachment reported about four times more often in users (39%) than nonusers (9%), adding to hair/scalp concerns seen in other studies. Student Protests Turn Violent: France’s school unrest escalated into arson and attacks on staff, with thousands arrested and hundreds of schools disrupted or closed, as students cite overcrowding, teacher shortages, and extreme classroom heat. Contraception Shift: A feature notes the pill’s decline in France (from 55.8% of users in 2005 to 26.8% in 2023), with IUDs now leading, reflecting changing preferences and growing mistrust. Public Health Watch: A separate report highlights how vaccine production delays can stall WHO regulatory progress, underscoring the need for stronger local manufacturing capacity.

France Budget Watch: France unveiled a €54bn adjustment plan for 2027, aiming to cut the deficit to 5% of GDP as public debt climbs to 121.7% in 2027 and debt-servicing costs rise to €91.2bn. Public Health & Safety: A French-Swiss lake at Lac des Brenets has dried up after record heat, with locals calling for help as tourism collapses and authorities face mounting criticism. Medical Error: A case in the UK highlights how a wrong-leg amputation can happen despite checks, with patients seeking compensation after safety failures. Infectious Disease Response: France is set to step up support for the DR Congo Ebola response as deaths surpass 4,000, amid fears of resurgence. Nutrition & Metabolic Health: A study links sugar in red meat to higher type 2 diabetes risk, adding to the debate on diet and chronic disease. Regulation & Vaccines: Nigeria’s regulator (NAFDAC) is pushing for vaccine manufacturing capacity to reach WHO maturity for vaccine lot release. GLP-1 Side Effects: New studies keep flagging nail and hair changes tied to GLP-1 use, raising awareness of lesser-known effects.

Women’s Health & Screening: Louane denounces “too-late” progress in women’s healthcare, calling out delays in breast cancer and endometriosis diagnosis and urging better symptom awareness and screening during Pink October. GLP-1 Side Effects: New studies link GLP-1 weight-loss/diabetes drugs to higher reports of hair loss and nail problems, including nail detachment and scalp irritation, though researchers stress the findings don’t prove direct cause. Infectious Disease Response: France pledges more support for the DRC Ebola outbreak as deaths top 4,000, with officials warning the virus could resurge and pushing for additional humanitarian funding. Healthcare Access Bottlenecks: WHO says aid into Gaza is slowed by “delay after delay,” with medical supplies stuck in Israel’s approval process for a median of 74 days, leaving hospitals unable to function fully. Public Health Risk: A 15-year-old in Marseille is arrested after allegedly using a makeshift flame-thrower to burn a woman’s face during student riots, highlighting the health dangers tied to unrest.

Public Health & Misinformation: The Philippines’ vaccination drive shows how social-media misinformation can fuel vaccine fear, with doctors finding no link between a child’s illness and a measles-rubella jab. Ebola Response: Congo’s deadliest Ebola outbreak is moving into a new phase as a trial enrolls 250+ people for an experimental post-exposure antiviral aimed at preventing infection after exposure. MAID & Abortion Access: A Nova Scotia hospital ends Catholic sponsorship, clearing the way for medical assistance in dying and abortion services under one roof. Nutrition & Lifestyle: Europe’s drinks market is shifting as alcohol sales soften but spending rises on low- and no-alcohol options, alongside more water, juices, and tea/coffee. Climate & Health: Tokyo’s record 35-day rain streak is linked to headaches and dizziness, while vegetable prices rise and tourism takes a hit. Health Tech/Pharma: A Phase 2b trial in The Lancet Infectious Diseases reports a nasal pertussis vaccine (BPZE1) boosting mucosal immunity in children.

GLP-1 Safety Watch: New research presented in Europe links GLP-1 weight-loss drugs (semaglutide, tirzepatide) with higher rates of nail problems, especially nail detachment, and also adds to reports of hair loss—researchers stress it’s an association, not proof of direct causation. Public Health & Climate: Copernicus data says summer 2026 heat stress hit 52% of Europe, with record temperatures and major river low flows—raising concerns for health systems and food supply. Ebola Update: DR Congo’s worst-ever Ebola outbreak has surpassed 4,000 deaths out of 8,300+ cases, with conflict and mistrust continuing to hamper response. Healthcare Governance: In Ghana, AMMREN, GHS and ALMA urge media to amplify community scorecards so patient concerns reach health managers and trigger fixes. France Context: A report on France’s fiscal plans flags potential pressure on social security and slower healthcare spending growth, as markets react to reform doubts.

School Health & Safety: France has closed around 400 high schools after a week of student protests over conditions and staffing, with the education minister citing “ultra-violent fringe groups” and reporting 65 staff injured, while classes move online in some cities. Public Health & Climate: Europe’s record heat and drought are hitting health and food systems hard, with estimates of €128bn in heatwave output losses in 2026 and major grain shortfalls after extreme weather. Infectious Disease Watch: West Nile virus is spreading in Europe, with the Netherlands reporting nine deaths among 56 cases, underscoring mosquito-borne risks during warm months. Healthcare Innovation & Industry: Danone and partners opened a €20m fermentation biotech scale-up platform in Clermont-Ferrand to speed lab discoveries into food-ingredient production. Nutrition & Prevention: New research links sugar in red meat and ultra-processed foods to higher type 2 diabetes risk, adding pressure for clearer dietary guidance.

Cancer & Prevention: A new IARC analysis links about 2.3 million cancer cases in 2024 (roughly 1 in 8) to infections, highlighting preventable drivers like HPV, H. pylori, hepatitis B/C, and EBV—a strong case for vaccination, screening, and infection control. Oncology Research: Roche reports evERA results in NEJM: giredestrant plus everolimus significantly improves progression-free survival in ER-positive advanced breast cancer after CDK4/6 inhibitor resistance. Dermatology Trial Update: Upadacitinib continues to show sustained repigmentation in non-segmental vitiligo through week 76 in Viti-Up data. Health Policy & Access: CMS finalizes the GLOBE model for Medicare Part B drugs starting Jan. 1, 2027, with revised savings estimates and potential lower out-of-pocket costs from April 1, 2027 for selected beneficiaries. Public Health Context (France): Student protests in France escalate, with reports of hundreds of school blockades and injuries—raising concerns for continuity of care and education-related wellbeing.